An Aussie social media influencer was rushed to hospital after she endured a severe allergic reaction to getting her lip ...

An immunotherapy kept multiple myeloma at bay for over 80 percent of patients in a three-year clinical trial, and the FDA ...

AJOVY demonstrated efficacy and a consistent safety profile in the SPACE trial, making it the first and only calcitonin ...

A woman claims an eyebrow tint left her looking like an ' alien' after she had an allergic reaction that caused her face to ...

Preliminary BRIUMVI U.S. fourth quarter and full year 2025 net product revenue of approximately $182 million and $594 million, respectively Full Year 2026 target total global revenue of approximately ...

Align Technology explains why bridging the gap between clinical planning and emotional connection is key for treatment ...

Pharmacogenetics and pharmacogenomics are increasingly recognised as playing a pivotal role in the advancement of personalised medicine, especially in the ...

The trial met its primary endpoint with a hazard ratio of 0.75, indicating a significant reduction in disease progression ...

An oncology pharmacist shares how a treatment takes a different approach to treating chronic graft-versus-host disease (GVHD) ...

Vitamin B12 is typically well-tolerated, but in very rare cases, there are serious side effects to be aware of. Learn more ...

Peanut oral immunotherapy is generally safe, but rare, severe immediate allergic reactions may emerge months into treatment, a real-world French study shows.

SAN DIEGO, Dec. 29, 2025 (GLOBE NEWSWIRE) -- ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a commercial-stage biopharmaceutical company dedicated to empowering at-risk patients and their caregivers to ...